Jalilol, Nurdia J.
HRN: 26-54-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/19/2025
CEFTRIAXONE 1G (VIAL)
01/19/2025
01/25/2025
IV
850 Mg
Q12H
CNS Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes